Pyridopyrimidines used as Plk1 (polo-like kinase) inhibitors
申请人:4SC AG
公开号:EP2100894A1
公开(公告)日:2009-09-16
The invention relates to pyridopyrimidinone compounds according to formula (I),
wherein the substituents and symbols are as defined in the description. The compounds are inhibitors of Plk1.